Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Net Equity Issued and Repurchased (2014 - 2025)

Lantheus Holdings (LNTH) posted quarterly Net Equity Issued and Repurchased of $2.0 million for Q1 2025, up 8.78% year-over-year from $1.8 million in Q1 2024, and up 21.88% quarter-over-quarter from $1.6 million in Q3 2024.

Lantheus Holdings (LNTH) Net Equity Issued and Repurchased (2014 - 2025) Analysis & Trends

Lantheus Holdings (LNTH) has reported Net Equity Issued and Repurchased for 11 consecutive years, with $2.0 million the latest figure, recorded in Q1 2025.

  • In Q1 2025, Net Equity Issued and Repurchased rose 8.78% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $3.6 million (changed 0.0% YoY), while the FY2024 annual figure was $3.4 million, up 78.48% from the prior year.
  • Net Equity Issued and Repurchased advanced to $2.0 million in Q1 2025 per LNTH's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $2.0 million in Q1 2025 and bottomed at -$1000.0 in Q4 2021.
  • Historically, Net Equity Issued and Repurchased has averaged $950800.0 across 5 years, with a median of $869000.0 in 2022.
  • Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased fell 7.92% — and 2024, when it soared 93.94%.
  • Lantheus Holdings' Net Equity Issued and Repurchased stood at -$1000.0 in 2021, then jumped by 79900.0% to $798000.0 in 2022, then grew by 24.44% to $993000.0 in 2023, then surged by 63.85% to $1.6 million in 2024, then grew by 21.88% to $2.0 million in 2025.
  • Business Quant data shows LNTH's Net Equity Issued and Repurchased at $2.0 million in Q1 2025, $1.6 million in Q3 2024, and $1.8 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.98 Mn
Mar 31, 2025 1.98 Mn
Sep 30, 2024 1.63 Mn
Sep 30, 2024 1.63 Mn
Mar 31, 2024 1.82 Mn
Mar 31, 2024 1.82 Mn
Sep 30, 2023 993,000.00
Sep 30, 2023 993,000.00
Mar 31, 2023 940,000.00
Mar 31, 2023 940,000.00
Sep 30, 2022 798,000.00
Sep 30, 2022 798,000.00
Mar 31, 2022 577,000.00
Mar 31, 2022 577,000.00
Dec 31, 2021 -1,000.00
Dec 31, 2021 -1,000.00
Sep 30, 2021 431,000.00
Sep 30, 2021 431,000.00
Mar 31, 2021 337,000.00
Mar 31, 2021 337,000.00